Updated drugs unit 3

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/37

encourage image

There's no tags or description

Looks like no tags are added yet.

38 Terms

1
New cards

LSD (lysergic acid diethylamide; no approved brand)

Type: Classic hallucinogen. Uses/effects: No FDA-approved medical use; alters perception, mood, and thinking. How: Acts on serotonin receptors, especially 5-HT2A receptors.

2
New cards

Psilocybin (no approved brand)

Type: Classic hallucinogen found in certain mushrooms. Uses/effects: No FDA-approved medical use; being studied for depression. How: The body converts it to psilocin, which acts on serotonin receptors, especially 5-HT2A.

3
New cards

Mescaline (found in peyote; no approved brand)

Type: Classic hallucinogen. Uses/effects: No FDA-approved medical use; alters perception, mood, and thinking. How: Acts on serotonin receptors, including 5-HT2A.

4
New cards

DMT (dimethyltryptamine; found in ayahuasca; no approved brand)

Type: Classic hallucinogen. Uses/effects: No FDA-approved medical use; produces intense changes in perception. How: Acts on serotonin receptors, including 5-HT2A. In ayahuasca, MAO-inhibiting compounds allow orally consumed DMT to remain active.

5
New cards

MDMA (Ecstasy or Molly; no approved brand)

Type: Mixed stimulant-entactogen. Uses/effects: Produces energy, empathy, and emotional openness; being studied with therapy for PTSD. How: Increases the release of serotonin, norepinephrine, and dopamine. MDMA-assisted PTSD therapy remains investigational.

6
New cards

Phencyclidine (PCP; formerly Sernyl)

Type: Dissociative drug and former anesthetic. Uses/effects: No current approved human medical use; causes dissociation and altered perception. How: Blocks NMDA glutamate receptors.

7
New cards

Ketamine (Ketalar)

Type: Dissociative anesthetic. Treats: Used for induction and maintenance of general anesthesia. How: Blocks NMDA glutamate receptors, producing anesthesia and dissociation.

8
New cards

Esketamine (Spravato)

Type: Dissociative antidepressant. Treats: Treatment-resistant depression in adults; also used with an oral antidepressant for depressive symptoms in adults with major depressive disorder and acute suicidal thoughts or behavior. How: Blocks NMDA receptors and affects glutamate signaling.

9
New cards

Dextromethorphan (DXM; Delsym and others)

Type: Cough suppressant; dissociative at high doses. Treats: Temporarily relieves cough. How: Reduces activity in the brain’s cough center; at high doses, NMDA receptor blockade contributes to dissociative effects.

10
New cards

Haloperidol (Haldol)

Type: First-generation or typical antipsychotic. Treats: Schizophrenia and certain other conditions. How: Primarily blocks dopamine D2 receptors, helping reduce psychotic symptoms.

11
New cards

Cariprazine (Vraylar)

Type: Atypical antipsychotic; sometimes called third-generation. Treats: Schizophrenia, certain bipolar I episodes, and depression as an add-on treatment. How: Partially activates dopamine D2 and D3 receptors and affects serotonin receptors.

12
New cards

Risperidone (Risperdal)

Type: Second-generation or atypical antipsychotic. Treats: Schizophrenia, certain bipolar symptoms, and irritability associated with autism. How: Blocks dopamine D2 and serotonin 5-HT2A receptors.

13
New cards

Aripiprazole (Abilify)

Type: Atypical antipsychotic; often called third-generation. Treats: Schizophrenia, bipolar disorder, and depression as an add-on treatment. How: Partially activates dopamine D2 receptors and affects serotonin receptors.

14
New cards

Selegiline (Emsam)

Type: Monoamine oxidase inhibitor, or MAOI. Treats: Depression. How: The skin patch inhibits monoamine oxidase, reducing the breakdown of serotonin, norepinephrine, and dopamine.

15
New cards

Amitriptyline (Elavil)

Type: Tricyclic antidepressant. Treats: Depression; also sometimes prescribed for nerve pain or migraine prevention. How: Blocks the reuptake of serotonin and norepinephrine.

16
New cards

Nortriptyline (Pamelor)

Type: Tricyclic antidepressant. Treats: Depression; also sometimes prescribed for nerve pain. How: Blocks the reuptake of norepinephrine and serotonin, with a relatively greater effect on norepinephrine.

17
New cards

Desipramine (Norpramin)

Type: Tricyclic antidepressant. Treats: Depression. How: Primarily blocks the reuptake of norepinephrine.

18
New cards

Imipramine (Tofranil)

Type: Tricyclic antidepressant. Treats: Depression and, in certain circumstances, childhood bed-wetting. How: Blocks the reuptake of serotonin and norepinephrine; its effect on bed-wetting is not fully understood.

19
New cards

Citalopram (Celexa)

Type: Selective serotonin reuptake inhibitor, or SSRI. Treats: Depression. How: Blocks serotonin reuptake, increasing serotonin availability between neurons.

20
New cards

Escitalopram (Lexapro)

Type: SSRI antidepressant. Treats: Depression and generalized anxiety disorder. How: Blocks serotonin reuptake, increasing serotonin availability between neurons.

21
New cards

Fluoxetine (Prozac)

Type: SSRI antidepressant. Treats: Depression, obsessive-compulsive disorder, panic disorder, and certain other conditions. How: Blocks serotonin reuptake, increasing serotonin availability between neurons.

22
New cards

Paroxetine (Paxil; Pexeva)

Type: SSRI antidepressant. Treats: Depression and several anxiety-related conditions, depending on the product. How: Blocks serotonin reuptake, increasing serotonin availability between neurons.

23
New cards

Sertraline (Zoloft)

Type: SSRI antidepressant. Treats: Depression, panic disorder, social anxiety disorder, obsessive-compulsive disorder, and PTSD. How: Blocks serotonin reuptake, increasing serotonin availability between neurons.

24
New cards

Duloxetine (Cymbalta)

Type: Serotonin-norepinephrine reuptake inhibitor, or SNRI. Treats: Depression, generalized anxiety disorder, and certain chronic pain conditions. How: Blocks the reuptake of serotonin and norepinephrine.

25
New cards

Venlafaxine (Effexor)

Type: SNRI antidepressant. Treats: Depression and certain anxiety disorders, depending on the formulation. How: Blocks the reuptake of serotonin and norepinephrine.

26
New cards

Desvenlafaxine (Pristiq)

Type: SNRI antidepressant. Treats: Major depressive disorder. How: Blocks the reuptake of serotonin and norepinephrine.

27
New cards

Levomilnacipran (Fetzima)

Type: SNRI antidepressant. Treats: Major depressive disorder. How: Blocks the reuptake of norepinephrine and serotonin.

28
New cards

Bupropion (Wellbutrin)

Type: Atypical antidepressant; norepinephrine-dopamine reuptake inhibitor. Treats: Depression; another bupropion product is used to help people stop smoking. How: Primarily blocks the reuptake of norepinephrine and dopamine.

29
New cards

Lithium (Lithobid and others)

Type: Mood stabilizer. Treats: Mania and helps prevent future mood episodes in bipolar disorder. How: Affects intracellular signaling and neurotransmission; its full mechanism is not completely understood.

30
New cards

Barbiturates (drug class; examples: phenobarbital and pentobarbital)

Type: Sedative-depressants. Treats: Certain seizures or other conditions depending on the drug; rarely preferred for routine anxiety. How: Enhance GABA-A receptor activity, increasing inhibitory signaling in the brain.

31
New cards

Benzodiazepines (drug class; examples: Xanax, Ativan, Valium, and Klonopin)

Type: Sedative-anxiolytics. Treats: Anxiety, panic symptoms, and certain other conditions depending on the drug. How: Enhance GABA-A receptor activity, increasing inhibitory signaling in the brain.

32
New cards

Buspirone (BuSpar)

Type: Non-benzodiazepine anxiolytic. Treats: Generalized anxiety. How: Acts mainly as a partial agonist at serotonin 5-HT1A receptors; its full benefit usually takes several weeks.

33
New cards

Propranolol (Inderal)

Type: Beta blocker. Treats: Certain heart and blood pressure conditions; sometimes used for physical symptoms of performance anxiety. How: Blocks beta-adrenergic receptors, reducing effects such as a racing heart and trembling.

34
New cards

Cannabis (marijuana; no single brand)

Type: Plant containing cannabinoids, including THC and CBD. Uses/effects: Produces effects such as relaxation and altered perception; the plant itself is not FDA-approved as a medication. How: Its compounds affect the endocannabinoid system in different ways.

35
New cards

Delta-9-tetrahydrocannabinol (Δ9-THC; no single brand)

Type: Intoxicating cannabinoid. Uses/effects: Produces the typical cannabis high and can increase appetite and alter perception. How: Partially activates cannabinoid receptors, especially CB1 receptors in the brain.

36
New cards

Cannabidiol (CBD; Epidiolex is one prescription product)

Type: Cannabinoid that does not produce the typical THC high. Uses: Prescription CBD is used for seizures associated with certain conditions. How: Its seizure-reducing mechanism is not fully understood and does not rely on strong direct CB1 activation.

37
New cards

Cannabidiol (Epidiolex)

Type: Prescription cannabinoid and antiseizure medication. Treats: Seizures associated with Lennox-Gastaut syndrome, Dravet syndrome, or tuberous sclerosis complex. How: Its exact antiseizure mechanism is not fully understood.

38
New cards

Dronabinol (Marinol)

Type: Synthetic delta-9-THC cannabinoid. Treats: AIDS-related loss of appetite with weight loss and certain chemotherapy-related nausea and vomiting. How: Activates cannabinoid receptors, including CB1 receptors, affecting appetite, nausea, and perception.